Literature DB >> 20189331

Three-year-old child with meroacrania - neurological signs.

Carolina Araújo Rodrigues Funayama1, Luzia Iara Pfeifer, Ester Silveira Ramos, Patrícia Zambroni Santucci, Israel Gomy, Adolfo Marcondes Amaral Neto.   

Abstract

Neurological findings in a three-year-old child with meroacrania provide new insights into how the nervous system develops and functions in the absence of superior levels of control from the time of origin. The girl is the first child of a non-consanguineous white Brazilian couple, born at term, weighing 2650 g and measuring 44 cm in length. Upon examination at 43 months, she had quadriplegia, global hypotonia with occasional body hypertonia in a decorticate posture, hyperreflexia, ankle clonus, and extensor plantar response. This case allowed us to verify that, in the absence of upper structures and subcortical nuclei, there are clear signs that suggest corticospinal primacy in motor functions without a substitute pathway. Sound orientation responses suggest the independence of the vestibular-acoustic-ocular system, and manifestations of responsiveness to the environment raise questions about consciousness.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20189331     DOI: 10.1016/j.braindev.2010.02.001

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  2 in total

1.  Cell necrosis, intrinsic apoptosis and senescence contribute to the progression of exencephaly to anencephaly in a mice model of congenital chranioschisis.

Authors:  Marc Oria; Soner Duru; Rebeca L Figueira; Federico Scorletti; Lucas E Turner; Irati Fernandez-Alonso; Alejandra Fernandez-Martin; Mario Marotta; Lourenco Sbragia; Aimen F Shaaban; Jose L Peiro
Journal:  Cell Death Dis       Date:  2019-09-26       Impact factor: 8.469

Review 2.  Eduard Gamper (1887-1938): cases and accidents.

Authors:  Evzen Ruzicka; Hartmann Hinterhuber; Hans Förstl
Journal:  J Neurol       Date:  2021-09-13       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.